Our results indicate that TFAP2A significantly reduces Ydsphk1 promoter activity, suggesting that this regulatory mechanism may serve as a critical checkpoint in immune responses, modulating Ydsphk1 expression during the early stages of infection. Here, TFAP2A is linked to infection.